Clinical Trials Directory

Trials / Completed

CompletedNCT04791800

Clinical Evaluation of the STANDARD™ Q Malaria/CRP Duo Test

Evaluation of the Clinical Performance of the STANDARD™ Q Malaria/CRP Duo Test (SD Biosensor, South Korea) for the Diagnosis of Malaria and the Detection of C-reactive Protein (CRP) in Fingerprick Blood of Febrile Patients

Status
Completed
Phase
Study type
Observational
Enrollment
1,808 (actual)
Sponsor
Foundation for Innovative New Diagnostics, Switzerland · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers

Summary

The aim of this study is to assess the clinical performance (sensitivity, specificity, positive and negative predictive values) of the STANDARD™ Q Malaria/CRP Duo Test when used by health care workers (HW) in a point of care (POC) setting in malaria endemic areas in India. Performance will be assessed in comparison with expert microscopy as the reference test for malaria, and with a high quality, commercially available C-Reactive Protein (CRP) test kit run on a laboratory machine as a reference test for CRP.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMalaria/CRP combination testTesting with a malaria/CRP combination test, in parallel with a standard malaria RDT (to guide case management), preparation of thin/thick films for expert malaria microscopy, and collection of venous blood for subsequent CRP quantification.

Timeline

Start date
2019-04-08
Primary completion
2020-03-16
Completion
2020-09-01
First posted
2021-03-10
Last updated
2021-03-10

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04791800. Inclusion in this directory is not an endorsement.